Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F
GLP-1 analogs have been developed for the treatment of type II diabetes mellitus
Seun Sowemimo, MD a New Jersey weight loss expert serving New Jersey, Staten Island and Brooklyn patients
There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease #osteoarthritis NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs
Disappointing results
Currently, only injectable or oral prescription medications can deliver proven GLP-1 effects for weight loss